Glyceroneogenesis and PEPCK-C: Pharmacological targets in type 2 diabetes;Glycéronéogenèse et PEPCK-C: Cibles pharmacologiques dans le diabète de type 2

Medecine/Sciences

Volumn 24, Issue 4, 2008, Pages 407-413

  Cadoudal, Thomas ^a   Fouque, Françoise ^a   Benelli, Chantal ^a   Forest, Claude ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AMINO ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FATTY ACID; GLUCOCORTICOID; GLYCEROPHOSPHATE; LACTIC ACID; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PYRUVIC ACID; TRIACYLGLYCEROL;

ADIPOSE TISSUE; DIET RESTRICTION; ESTERIFICATION; GENETIC TRANSCRIPTION; HUMAN; HYPOLIPEMIA; INSULIN RESISTANCE; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN TARGETING; REVIEW; RISK FACTOR;

EID: 42449089475     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2008244407     Document Type: Review

References (35)

1. Keller U. From obesity to diabetes. Int J Vitam Nutr Res 2006 ; 76 : 172-7.
2. McGarry J. D. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 1992 ; 258 : 766-70.
3. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963 ; 1 : 785-9.
4. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000 ; 106 : 171-6.
5. Zimmermann R, Strauss JG, Haemmerle G, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004 ; 306 : 1383-6.
6. Londos C, Sztalryd C, Tansey JT, Kimmel AR. Role of PAT proteins in lipid metabolism. Biochimie 2005 ; 87 : 45-9.
7. Tai ES, Ordovas JM. The role ofperilipin in human obesity and insulin resistance. Curr Opin Lipidol 2007 ; 18 : 152-6.
8. Vaughan M. The production and release of glycerol by adipose tissue incubated in vitro. J Biol Chem 1962 ; 237 : 3354-8.
9. Tordjman J, Chauvet G, Quette J, et al. Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem 2003 ; 278 : 18785-90.
10. Leroyer SN, Tordjman J, Chauvet G, et al. Rosiglitazone controls fatty acid cycling in human adipose tissue by means of glyceroneogenesis and glycerol phosphorylation. J Biol Chem 2006 ; 281 : 13141-9.
11. Ballard FJ, Hanson RW, Leveille GA. Phosphoenolpyruvate carboxykinase and the synthesis of glyceride-glycerol from pyruvate in adipose tissue. J Biol Chem 1967 ; 242 : 2746-50.
12. Antras-Ferry J, Robin P, Robin D, Forest C. Fatty acids and fibrates are potent inducers of transcription of the phosphenolpyruvate carboxykinase gene in adipocytes. Eur J Biochem 1995 ; 234 : 390-6.
13. Chakravarty K, Cassuto H, Reshef L, Hanson RW. Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C. Crit Rev Biochem Mol Biol 2005 ; 40 : 129-54.
14. Tontonoz P, Hu E, Devine J, et al. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 1995 ; 15 : 351-7.
15. Devine JH, Eubank DW, Clouthier DE, et al. Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor gamma and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo. J Biol Chem 1999 ; 274 : 13604-12.
16. Willson TM, Brown PJ, Sternbach DD, Henke BR. The PPARs : from orphan receptors to drug discovery. J Med Chem 2000 ; 43 : 527-50.
17. Okuno A, Tamemoto H, Tobe K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest 1998 ; 101 : 1354-61.
18. Crossno JT Jr, Majka SM, Grazia T, et al. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest 2006 ; 116 : 3220-8.
19. Guerre-Millo M. Adipose tissue and adipakines : for better or worse. Diabetes Metab 2004 ; 30 : 13-9.
20. Glorian M, Duplus E, Beale EG, et al. A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes. Biochimie 2001 ; 83 : 933-43.
21. Duplus E, Benelli C, Reis AF, et al. Expression of phosphoenolpyruvate carboxykinase gene in human adipose tissue : induction by rosiglitazone and genetic analyses of the adipocyte-specific region of the promoter in type 2 diabetes. Biochimie 2003 ; 85 : 1257-64.
22. Hallakou S, Doare L, Foufelle F, et al. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes 1997 ; 46 : 1393-9.
23. Cadoudal T, Blouin JM, Collinet M, et al. Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes. Diabetologia 2007 ; 50 : 666-75.
24. Boden G, Homko C, Mozzoli M, et al. Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients. Diabetes 2005 ; 54 : 880-5.
25. Davies GF, Khandelwal RL, Wu L, et al. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone : a peroxisome proliferator-activated receptor-gamma (PPARgamma)-independent, antioxidant-related mechanism. Biochem Pharmacol 2001 ; 62 : 1071-9.
26. Guan HP, Li Y, Jensen W, et al. A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat Med 2002 ; 8 : 1122-8.
27. Tan GD, Debard C, Tiraby C, et al. A "futile cycle" induced by thiazolidinediones in human adipose tissue? Nat Med 2003 ; 9 : 811-2.
28. Franckhauser S, Antras-Ferry J, Robin P, et al. Expression of the phosphoenolpyruvate carboxykinase gene in 3T3-F442A adipose cells : opposite effects of dexamethasone and isoprenaline on transcription. Biochem J 1995 ; 305 : 65-71.
29. Duplus E, Glorian M, Tordjman J, et al. Evidence for selective induction of phosphoenolpyruvate carboxykinase gene expression by unsaturated and nonmetabolized fatty acids in adipocytes. J Cell Biochem 2002 ; 85 : 651-61.
30. Duplus E, Forest C. Is there a single mechanism for fatty acid regulation of gene transcription? Biochem Pharmacol 2002 ; 64 : 893-901.
31. Bogacka I, Xie H, Bray GA, Smith SR. The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo. Diabetes Care 2004 ; 27 : 1660-7.
32. El Hani H, Zouali H, Philippi A, et al. Indication for genetic linkage of the phosphoenolpyruvate carboxykinase (PCK1) gene region on chromosome 20q to non-insulin-dependent diabetes mellitus. Diabetes Metab 1996 ; 22 : 451-4.
33. Cao H, Van der Veer E, Ban BR, et al. Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004 ; 89 : 898-903.
34. Hakimi P, Yang J, Casadesus G, et al. Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse. J Biol Chem 2007 ; 282 : 328-44.
35. Girard J. Rôle des acides gras libres dans la sécré tion et l'action de l'insuline : mécanismes de la lipotoxicité. Med Sci (Paris) 2003 ; 19 : 827-33.